Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Apple Hospitality REIT
APLE
$3.93B
| $20.8M | 0.01% |
1,320,334
-875,630
| -40% | -$13.1M |
|
1277
CALL
Illumina
ILMN
$34.1B
| $20.7M | 0.01% |
52,531
+411
| +0.8% | +$189K |
|
1278
DaVita
DVA
$11.3B
| $20.7M | 0.01% |
178,103
-72,326
| -29% | -$9.06M |
|
1279
NetEase
NTES
$82.2B
| $20.6M | 0.01% |
241,037
-706,063
| -75% | -$66.7M |
|
1280
Range Resources
RRC
$9.6B
| $20.6M | 0.01% |
908,876
+812,345
| +842% | +$13.2M |
|
1281
MKS Inc
MKSI
$18.3B
| $20.6M | 0.01% |
136,174
-157,608
| -54% | -$24.2M |
|
1282
Cracker Barrel
CBRL
$1.28B
| $20.5M | 0.01% |
146,614
+81,799
| +126% | +$11.5M |
|
1283
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $20.5M | 0.01% |
297,800
+150,100
| +102% | +$10.7M |
|
1284
W.R. Berkley
WRB
$25.5B
| $20.5M | 0.01% |
630,074
-1,385,193
| -69% | -$45.7M |
|
1285
flyExclusive
FLYX
$133M
| $20.5M | 0.01% |
+2,107,500
| New | +$20.4M |
|
1286
CALL
Novartis
NVS
$303B
| $20.4M | 0.01% |
+250,000
| New | +$22.5M |
|
1287
HF Sinclair
DINO
$16.9B
| $20.4M | 0.01% |
617,041
+581,373
| +1,630% | +$17.7M |
|
|
PCGU
1288
DELISTED
PG&E Corporation
PCGU
| $20.4M | 0.01% |
211,901
-100,360
| -32% | -$9.52M |
|
1289
PUT
Rithm Capital
RITM
$5.7B
| $20.4M | 0.01% |
1,850,000
+650,000
| +54% | +$6.68M |
|
1290
Mirion Technologies
MIR
$3.64B
| $20.3M | 0.01% |
1,986,604
+1,933,597
| +3,648% | +$19.5M |
|
|
ELP
1291
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $20.3M | 0.01% |
3,885,920
-2,487,740
| -39% | -$12M |
|
1292
PUT
Simon Property Group
SPG
$71.2B
| $20.3M | 0.01% |
156,100
+153,900
| +6,995% | +$20M |
|
1293
Corteva
CTVA
$55.1B
| $20.2M | 0.01% |
480,865
+68,079
| +16% | +$2.95M |
|
1294
Idexx Laboratories
IDXX
$43.6B
| $20.2M | 0.01% |
32,535
+27,973
| +613% | +$18.8M |
|
1295
Tandem Diabetes Care
TNDM
$1.51B
| $20.2M | 0.01% |
169,462
-132,950
| -44% | -$14.6M |
|
|
LDL
1296
DELISTED
Lydall, Inc.
LDL
| $20.2M | 0.01% |
325,611
+91,766
| +39% | +$5.65M |
|
1297
Ironwood Pharmaceuticals
IRWD
$717M
| $20.2M | 0.01% |
1,545,482
-213,471
| -12% | -$2.76M |
|
|
FSR
1298
DELISTED
Fisker Inc.
FSR
| $20.2M | 0.01% |
+1,376,478
| New | +$20.7M |
|
1299
CALL
Illinois Tool Works
ITW
$80.1B
| $20.1M | 0.01% |
97,200
+53,600
| +123% | +$12.1M |
|
|
IBTX
1300
DELISTED
Independent Bank Group, Inc.
IBTX
| $20M | 0.01% |
282,063
+13,856
| +5% | +$965K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.